SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $158,000 | -13.7% | 70,814 | +16.3% | 0.00% | 0.0% |
| Q3 2014 | $183,000 | -16.8% | 60,882 | +13.0% | 0.00% | -50.0% |
| Q2 2014 | $220,000 | +56.0% | 53,878 | +64.9% | 0.00% | +100.0% |
| Q1 2014 | $141,000 | -17.5% | 32,668 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $171,000 | -17.0% | 32,668 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $206,000 | +26.4% | 32,668 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $163,000 | – | 32,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |